Cite
Jönsson M, Ekstrand A, Edekling T, et al. Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor. BMC Clin Pathol. 2009;9:8doi: 10.1186/1472-6890-9-8.
Jönsson, M., Ekstrand, A., Edekling, T., Eberhard, J., Grabau, D., Borg, D., & Nilbert, M. (2009). Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor. BMC clinical pathology, 98. https://doi.org/10.1186/1472-6890-9-8
Jönsson, Mats, et al. "Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor." BMC clinical pathology vol. 9 (2009): 8. doi: https://doi.org/10.1186/1472-6890-9-8
Jönsson M, Ekstrand A, Edekling T, Eberhard J, Grabau D, Borg D, Nilbert M. Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor. BMC Clin Pathol. 2009 Oct 15;9:8. doi: 10.1186/1472-6890-9-8. PMID: 19832985; PMCID: PMC2766396.
Copy
Download .nbib